Paul Damon & Associates, Inc. Penumbra Inc Transaction History

Paul Damon & Associates, Inc.

  • $162 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023
SELL
$271.54 - $344.06 $81,462 - $103,218
-300 Reduced 23.08%
1,000 $344 Million
Q1 2023

May 15, 2023
SELL
$220.43 - $278.69 $49,596 - $62,705
-225 Reduced 14.75%
1,300 $362 Million
Q4 2022

Feb 07, 2023
BUY
$151.88 - $228.5 $231,617 - $348,462
1,525 New
1,525 $339 Million

Others Institutions Holding PEN

# of Institutions
479
Shares Held
28.8M
Call Options Held
346K
Put Options Held
62.3K
View Full List

About Penumbra Inc

PEN Quotes by TradingView
  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $8.79B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Paul Damon & Associates, Inc. Portfolio

Follow Paul Damon & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paul Damon & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paul Damon & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email